Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

Shares of Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.30 and traded as high as $3.50. Sonoma Pharmaceuticals shares last traded at $3.10, with a volume of 811,769 shares trading hands.

Sonoma Pharmaceuticals Price Performance

The business’s 50-day moving average price is $3.12 and its 200-day moving average price is $1.30. The firm has a market capitalization of $2.98 million, a PE ratio of -0.62 and a beta of 1.38.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Sonoma Pharmaceuticals stock. Ground Swell Capital LLC purchased a new stake in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,400 shares of the company’s stock, valued at approximately $32,000. Ground Swell Capital LLC owned 1.08% of Sonoma Pharmaceuticals as of its most recent SEC filing. 1.95% of the stock is owned by institutional investors.

Sonoma Pharmaceuticals Company Profile

Sonoma Pharmaceuticals, Inc, develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis.